Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.00 0.04% 11,170.00 11,168.00 11,172.00 11,222.00 11,102.00 11,200.00 494,638 14:32:57
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,668.9 -196.0 5.9 1,686.5 173,036

AstraZeneca Reports Promising Data From Lung Cancer Trial

09/08/2022 11:49am

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Jun 2022 to Dec 2022

Click Here for more Astrazeneca Charts.

By Ian Walker


AstraZeneca PLC said Tuesday that initial results from a trial of datopotamab deruxtecan-based combinations show promising clinical activity in patients with advanced non-small-cell lung cancer.

The pharmaceutical giant said that the trial showed encouraging efficacy and safety results that justify further studies.

Datopotamab deruxtecan is being jointly developed by AstraZeneca and Daiichi Sankyo.

"We look forward to continuing this important research with the goal of providing a new, effective treatment option for patients with advanced non-small-cell lung cancer," Astra's Chief Medical Officer and Oncology Chief Development Officer Cristian Massacesi said.


Write to Ian Walker at


(END) Dow Jones Newswires

August 09, 2022 06:34 ET (10:34 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221201 14:47:58